Clinical Trial Update: A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating the menin inhibitor revumenib in patients with leukemia associated with upregulation of HOX genes. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Revumenib (revumenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, HOX Gene | Phase 2 | Status: RECRUITING